Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)
Metaxas, Y., Früh, M., Eboulet, E.I., Grosso, F., Pless, M., Zucali, P.A., Ceresoli, G.L., Mark, M., Schneider, M., Maconi, A., Perrino, M., Biaggi-Rudolf, C., Froesch, P., Schmid, S., Waibel, C., Appenzeller, C., Rauch, D., von Moos, R.
Published in Annals of oncology (01.04.2020)
Published in Annals of oncology (01.04.2020)
Get full text
Journal Article
SAKK 17/16 - Lurbinectedin monotherapy in patients with progressive malignant pleural mesothelioma: A multicenter, single-arm phase II trial
Metaxas, Y., Xyrafas, A., Mark, M.T., Pless, M., Frueh, M., Froesch, P.R., Schneider, M., Biaggi Rudolf, C., Grosso, F., von Moos, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study
Mark, M., Rusakiewicz, S., Früh, M., Hayoz, S., Grosso, F., Pless, M., Zucali, P., Ceresoli, G.L., Maconi, A., Schneider, M., Froesch, P., Tarussio, D., Benedetti, F., Dagher, J., Kandalaft, L., von Moos, R., Tissot-Renaud, S., Schmid, S., Metaxas, Y.
Published in ESMO open (01.06.2022)
Published in ESMO open (01.06.2022)
Get full text
Journal Article
Further anthropological and pathological arguments related to St Louis’ scurvy and infection signs on the Notre-Dame mandible (Paris, France)
Charlier, P., Froesch, P., Prades, L., Augias, A., Perciaccante, A., Appenzeller, O., Lippi, D., Balloni, S., Bianucci, R.
Published in Journal of stomatology, oral and maxillofacial surgery (01.04.2020)
Published in Journal of stomatology, oral and maxillofacial surgery (01.04.2020)
Get full text
Journal Article
The mandible of Saint-Louis (1270 AD): Retrospective diagnosis and circumstances of death
Charlier, P., Augias, A., Benmoussa, N., Rainsard, P., Froesch, P., Richardin, P., Froment, A., Bianucci, R., Appenzeller, O., Perciaccante, A., Lippi, D., Prades, L.
Published in Journal of stomatology, oral and maxillofacial surgery (01.04.2020)
Published in Journal of stomatology, oral and maxillofacial surgery (01.04.2020)
Get full text
Journal Article
143PD Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial
Gautschi, O., Li, Q., Matter-Walstra, K., Betticher, D., Frueh, M., Rauch, D., Pless, M., Froesch, P., Mach, N., Ochsenbein, A.
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article
An archeology of parturition in prehumans: Evolutionary trends and limits
Charlier, P, Coppens, Y, Chene, G, Augias, A, Jacqueline, S, Froesch, P, Huynh-Charlier, I
Published in Gynécologie, obstétrique, fertilité & sénologie (01.02.2017)
Published in Gynécologie, obstétrique, fertilité & sénologie (01.02.2017)
Get full text
Journal Article
1817TiPSAKK 17/16 - Lurbinectedin monotherapy in patients with progressive malignant pleural mesothelioma: A multicenter, single-arm phase II trial
Metaxas, Y, Xyrafas, A, Mark, M T, Pless, M, Frueh, M, Froesch, P R, Schneider, M, Biaggi Rudolf, C, Grosso, F, von Moos, R
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P2.12-21 Outcomes with Immune Checkpoint Inhibitors (ICI) for Relapsed Small Cell Lung Cancer (SCLC) in a Swiss Cohort
Mauti, L., Schmid, S., Demmer, I., Friedlaender, A., Blum, V., Rothschild, S., Bouchaab, H., Froesch, P., Britschgi, C., Koenig, D., Wannesson, L., Janthur, W., Schaer, S., Addeo, A., Jochum, W., Früh, M.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
1843OSAKK 17/16 - Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm phase II trial
Metaxas, Y, Frueh, M, Eboulet, E I, Grosso, F, Pless, M, Zucali, P A, Ceresoli, G L, Mark, M T, Schneider, M, Roveta, A, Perrino, M R A, Biaggi Rudolf, C, Froesch, P R, Schmidt, S, Waibel, C, Appenzeller, C, Rauch, D, von Moos, R
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Pembrolizumab as second or further line treatment in relapsed malignant pleural mesothelioma: A Swiss registry
Mauti, L.A., Klingbiel, D., Schmid, S., Bouchaab, H., Bartnick, T., Gautschi, O., Rothschild, S.I., Loeffler, M., Froesch, P., Petrausch, U., Wolleb Schild, S., Mingrone, W., Pratsch Peter, S., Savic Prince, S., Pless, M., von Moos, R., Metaxas, Y.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
P84.03 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients
Peled, N., Gillis, R., Kilickap, S., Froesch, P., Orlov, S., Filippova, E., Demirci, U., Christopoulos, P., Cicin, I., Bugdayci Basal, F., Yilmaz, C., Fedor, M., Korkmaz, T., Paydas, S., Gautschi, O., Zirtiloglu, A., Eralp, Y., Cinkir, H.Y., Sezer, A., Erman, M., Tural, D., Turna, H.Z., Mazieres, J., Dudnik, E., Reguart, N., Camidge, R., Ng, T.L., Senler, F. Cay, Beypınar, İ., Yazılıtaş, D., Demirkazik, A., Karaoğlu, A., Okutur, K., Şenol Coşkun, H., Nahit Şendur, M.A., Isikdogan, A., Cabuk, D., Yumuk, P.F., Yıldız, I., Kaplan, M.A., Özyılkan, Ö., Öztop, İ., Olmez, O.F., Aydin, K., Aydıner, A., Meydan, N., Grinberg, R., Roisman, L.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
First-line chemo-immunotherapy in SCLC: outcomes of a binational real-world study
Moliner, L., Zellweger, N., Schmid, S., Bertschinger, M., Waibel, C., Cerciello, F., Froesch, P., Mark, M., Bettini, A., Häuptle, P., Blum, V., Holer, L., Hayoz, S., Früh, M., Ahmed, S., Bhagani, S., Steele, N., Gray, H.J., Robinson, S.D., Davidson, M., Cox, S., Khalid, T., Geldart, T.R., Nolan, L., Scott, D.C., Hennah, L., Newsom-Davis, T., Rathbone, E., Handforth, C., Denton, A., Merchant, S., Blackhall, F., Mauti, L.A., Califano, R., Rothschild, S.I.
Published in JTO clinical and research reports (01.10.2024)
Published in JTO clinical and research reports (01.10.2024)
Get full text
Journal Article
Bevacizumab plus pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: update from the SAKK19/09 trial
Gautschi, O, Rothschild, S.I, Li, Q, Matter-Walstra, K, Zippelius, A, Betticher, D, Früh, M, Stahel, R.A, Cathomas, R, Rauch, D, Pless, M, Peters, S, Froesch, P, Zander, T, Schneider, M, Biaggi, C, Mach, N, Ochsenbein, A.F
Published in Clinical lung cancer (2016)
Published in Clinical lung cancer (2016)
Get full text
Journal Article
Bevacizumab (B) and erlotinib (E) as first-line therapy in metastatic nonsquamous non-small cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression (PD): A multicenter phase II trial, SAKK 19/05
Zappa, F., Droege, C., Betticher, D. C., von Moos, R., Brutsche, M. H., Baty, F., Bubendorf, L., Ochsenbein, A., Oppliger Leibundgut, E., Gautschi, O., Froesch, P., Stahel, R. A., Rauch, D., Schmid, P., Mayer, M., Crowe, S., Brauchli, P., Ribi, K., Pless, M.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
46,XX/46,XY chimerism in a phenotypically normal man
Schoenle, E, Schmid, W, Schinzel, A, Mahler, M, Ritter, M, Schenker, T, Metaxas, M, Froesch, P, Froesch, E R
Published in Human genetics (01.01.1983)
Published in Human genetics (01.01.1983)
Get more information
Journal Article